Doxorubicin Hydrochloride
Doxorubicin (Adriamycin, NSC 123127, DOX) HCl is an antibiotic agent that inhibits DNA topoisomerase II and induces DNA damage, mitophagy and apoptosis in tumor cells. Doxorubicin reduces basal phosphorylation of AMPK. Doxorubicin is used in the concomitant treatment of HIV-infected patients but is found to be at high risk of HBV reactivation.
Inquire / Order:
manager@chemfaces.com
Technical Inquiries:
service@chemfaces.com
Tel:
+86-27-84237783
Fax:
+86-27-84254680
Address:
1 Building, No. 83, CheCheng Rd., Wuhan Economic and Technological Development Zone, Wuhan, Hubei 430056, PRC
Providing storage is as stated on the product vial and the vial is kept tightly sealed, the product can be stored for up to
24 months(2-8C).
Wherever possible, you should prepare and use solutions on the same day. However, if you need to make up stock solutions in advance, we recommend that you store the solution as aliquots in tightly sealed vials at -20C. Generally, these will be useable for up to two weeks. Before use, and prior to opening the vial we recommend that you allow your product to equilibrate to room temperature for at least 1 hour.
Need more advice on solubility, usage and handling? Please email to: service@chemfaces.com
The packaging of the product may have turned upside down during transportation, resulting in the natural compounds adhering to the neck or cap of the vial. take the vial out of its packaging and gently shake to let the compounds fall to the bottom of the vial. for liquid products, centrifuge at 200-500 RPM to gather the liquid at the bottom of the vial. try to avoid loss or contamination during handling.
J Sep Sci.2022, 45(18):3556-3566.
J Enzyme Inhib Med Chem.2019, 34(1):134-143
Int J Mol Sci.2022, 23(1):538.
Molecules.2023, 28(10):4121.
Fitoterapia.2018, 124:92-102
Foods.2021, 10(11):2627.
Pak J Pharm Sci.2018, 31:311-315
Foods.2023, 12(6):1227.
Front Pharmacol.2019, 10:1355
Biomed Pharmacother.2021, 139:111585.
Related and Featured Products
Food Chem Toxicol,2010 Jun;48(6):1425-38.
New advances in molecular mechanisms and the prevention of adriamycin toxicity by antioxidant nutrients.[Pubmed:
20385199]
Anthracyclines (doxorubicin, daunorubicin, epirubicin, and idarubicin) are currently the most effective group of anti-neoplastic drugs used in clinical practice. Of these, doxorubicin (also called adriamycin) is a key chemotherapeutic agent in cancer treatment, although its use is limited as a consequence of the chronic and acute toxicity associated with this drug. The molecular mechanisms of doxorubicin account for both the anti-cancer and the toxic side effects. Many antioxidants have been assayed, with positive or negative results, to prevent the toxicity of doxorubicin.
METHODS AND RESULTS:
The present review has two main goals: (1) to report the latest findings regarding the molecular mechanisms of doxorubicin toxicity; (2) to update our understanding of the role of natural antioxidants in preventive therapy against doxorubicin-induced toxicity. This review provides new evidence for the chemoprevention of doxorubicin toxicity, making use of natural antioxidants - in particular vitamin E, vitamin C, coenzyme Q, carotenoids, vitamin A, flavonoids, polyphenol, resveratrol, antioxidant from virgin olive oil and selenium - and offers new insights into the molecular mechanisms of doxorubicin toxicity with respect to DNA damage, free radicals and other parameters.
Cancer Res,2009 May 15;69(10):4294-300.
Enhancing the antitumor activity of adriamycin and ionizing radiation.[Pubmed:
19401447]
Animal Models: Female athymic nude mice injected s.c. with MB231 cells
Dosages: 3 mg/kg/day
Administration: Delivered intratumorly
Nat Rev Cancer,2009 May;9(5):338-50.
Targeting DNA topoisomerase II in cancer chemotherapy.[Pubmed:
19377506]
METHODS AND RESULTS:
Recent molecular studies have expanded the biological contexts in which topoisomerase II (TOP2) has crucial functions, including DNA replication, transcription and chromosome segregation. Although the biological functions of TOP2 are important for ensuring genomic integrity, the ability to interfere with TOP2 and generate enzyme-mediated DNA damage is an effective strategy for cancer chemotherapy. The molecular tools that have allowed an understanding of the biological functions of TOP2 are also being applied to understanding the details of drug action.
CONCLUSIONS:
These studies promise refined targeting of TOP2 as an effective anticancer strategy.
